BRIEF published on 06/16/2026 at 10:10, 4 months 25 days ago Giorgio Bargiani Wins Prestigious Bartending Award Mixology Europe's 50 Best Bars Giorgio Bargiani Connaught Bar Altos Bartenders' Bartender Award
BRIEF published on 06/16/2026 at 10:10, 4 months 25 days ago Giorgio Bargiani remporte un prestigieux prix de barman Mixologie Les 50 Meilleurs Bars D'Europe Giorgio Bargiani Connaught Bar Prix Altos Des Barmans
BRIEF published on 06/16/2026 at 10:05, 4 months 25 days ago Shell Recharge and SINEXCEL Open Joint Innovation Lab for EV Charging Sustainable Energy EV Charging Innovation Lab Shell Recharge SINEXCEL Partnership
BRIEF published on 06/16/2026 at 10:05, 4 months 25 days ago Shell Recharge et SINEXCEL ouvrent un laboratoire d'innovation commun pour la recharge des véhicules électriques Énergie Durable Laboratoire D'innovation Recharge Des Véhicules Électriques Recharge Shell Partenariat SINEXCEL
BRIEF published on 06/16/2026 at 10:05, 4 months 25 days ago S&P Upgrades BarmeniaGothaer Ratings to “A+”, Outlook Stable S&P Global Ratings Rating Upgrade Financial Stability BarmeniaGothaer Insurance Merger
BRIEF published on 06/16/2026 at 10:05, 4 months 25 days ago S&P relève la notation de BarmeniaGothaer à « A+ », perspective stable S&P Global Ratings Stabilité Financière BarmeniaGothaer Amélioration De La Notation Fusion D'assurances
BRIEF published on 06/16/2026 at 10:05, 4 months 25 days ago PL BioScience Welcomes Maik W. Jornitz to Board of Directors Board Of Directors Biopharmaceutical Growth Human Platelet Lysate PL BioScience Maik W. Jornitz
BRIEF published on 06/16/2026 at 10:05, 4 months 25 days ago PL BioScience accueille Maik W. Jornitz au sein de son conseil d'administration. Conseil D'administration Croissance Biopharmaceutique Lysat Plaquettaire Humain PL BioScience Maik W. Jornitz
BRIEF published on 06/16/2026 at 10:00, 4 months 25 days ago Innovative Molecules Advances with New EBV Antiviral Program Clinical-stage Innovative Molecules EBV Virology Pipeline Antiviral Program
BRIEF published on 06/16/2026 at 10:00, 4 months 25 days ago Des molécules innovantes progressent grâce à un nouveau programme antiviral contre le virus d'Epstein-Barr Stade Clinique Molécules Innovantes EBV Pipeline De Virologie Programme Antiviral
Published on 11/11/2026 at 10:30, 16 minutes ago Temas Engages Arcstone Canada for Capital Markets Advisory and Investor-Communications Services
Published on 11/11/2026 at 03:30, 7 hours 16 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 10 hours 6 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 11 hours 16 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 11 hours 46 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 10:10, 36 minutes ago EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Published on 11/11/2026 at 10:00, 46 minutes ago GBC AG and Apaton Finance invite investors to the Zefiro Investor Day on November 19, 2026
Published on 11/11/2026 at 09:40, 1 hour 5 minutes ago Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Published on 11/11/2026 at 09:25, 1 hour 21 minutes ago DOBOT Unveils Three New Products at Its 2026 Robotics Ecosystem Conference
Published on 11/11/2026 at 09:05, 1 hour 41 minutes ago DeepL unveils Aure, its most lifelike Voice AI translation model yet
Published on 11/10/2026 at 18:00, 16 hours 46 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 17 hours 1 minute ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 17 hours 11 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 17 hours 14 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
